Earlier this week, the Antitrust Division of the Department of Justice (DOJ) filed a lawsuit seeking to unwind Parker-Hannifin’s US$4.3 billion consummated acquisition of Clarcor.
This is a notable challenge for two reasons. First, it is the DOJ’s first merger challenge under the Trump Administration. Second, and more importantly, the parties reported the transaction under the Hart-Scott-Rodino (HSR) Act; the HSR waiting period expired without a challenge; and the transaction closed–all more than seven months ago.
While the antitrust agencies regularly investigate, and sometimes challenge, consummated non-HSR reportable transactions, enforcement against reported transactions after the waiting period has elapsed is exceedingly rare. The Parker-Hannifin complaint is a stark reminder that US antitrust enforcers can, and will, investigate and challenge closed mergers–in rare circumstances, even after they had cleared the transaction.
Full Content: Mondaq
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
UK Regulator to Investigate Aviva’s £3.6bn Acquisition of Direct Line
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas